Heather A Behanna

Author PubWeight™ 10.90^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Heparin binding nanostructures to promote growth of blood vessels.	Nano Lett	2006	2.65
2	Glia proinflammatory cytokine upregulation as a therapeutic target for neurodegenerative diseases: function-based and target-based discovery approaches.	Int Rev Neurobiol	2007	1.59
3	Glial activation links early-life seizures and long-term neurologic dysfunction: evidence using a small molecule inhibitor of proinflammatory cytokine upregulation.	Epilepsia	2007	1.32
4	Inhibition of glial cell activation ameliorates the severity of experimental autoimmune encephalomyelitis.	Neurosci Res	2007	1.27
5	Development of a novel therapeutic suppressor of brain proinflammatory cytokine up-regulation that attenuates synaptic dysfunction and behavioral deficits.	Bioorg Med Chem Lett	2006	1.18
6	De novo and molecular target-independent discovery of orally bioavailable lead compounds for neurological disorders.	Curr Alzheimer Res	2006	0.88
7	Inhibition of experimental autoimmune encephalomyelitis by a novel small molecular weight proinflammatory cytokine suppressing drug.	J Neuroimmunol	2008	0.88
8	Molecular properties and CYP2D6 substrates: central nervous system therapeutics case study and pattern analysis of a substrate database.	Drug Metab Dispos	2009	0.79
9	Supramolecular fluorophores for biological studies: phenylene vinylene-amino acid amphiphiles.	Chem Biol	2005	0.77
10	Mechanism analysis of long-term graft survival by monocarboxylate transporter-1 inhibition.	Transplantation	2010	0.75